Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Yukiteru Fujishima"'
Autor:
Yukiteru Fujishima, Norifumi Sugawara, Shigeki Ito, Tatsuo Oyake, Yuka Takemasa-Fujisawa, Yoji Ishida, Yasuhiko Tsukushi, Ichiro Hanamura, Takahiro Mine, Shugo Kowata, Yusei Aoki
Publikováno v:
Annals of hematology. 98(5)
Febrile neutropenia is often observed in patients with hematologic malignancies, especially in those with acute leukemia. Meropenem has potent and broad antibacterial activity against gram-positive and gram-negative bacteria, and is recommended as fi
Autor:
Akiko Yashima-Abo, Tadashi Shimoyama, Shigeki Ito, Shugo Kowata, Yukiteru Fujishima, Yoji Ishida, Kazunori Murai
Publikováno v:
European Journal of Haematology. 93:290-296
Bortezomib is a potent proteasome inhibitor that has been extensively used to treat multiple myeloma. One of the most common grade 3 adverse events is cyclic thrombocytopenia. In this study, we studied the mechanism by which bortezomib induces thromb
Autor:
Shugo, Kowata, Yukiteru, Fujishima, Yuzo, Suzuki, Yasuhiko, Tsukushi, Tatsuo, Oyake, Ryou, Togawa, Kotaro, Oyama, Akio, Ikai, Shigeki, Ito, Yoji, Ishida
Publikováno v:
[Rinsho ketsueki] The Japanese journal of clinical hematology. 57(8)
Recent advances in surgical corrections and supportive care for congenital heart disease have resulted in increasing numbers of adult survivors who may develop hematological malignancies. Treatments including chemotherapy for such patients may cause
Autor:
Yukiteru, Fujishima, Shigeki, Ito
Publikováno v:
Nihon rinsho. Japanese journal of clinical medicine. 73
Autor:
Yoji Ishida, Kazunori Murai, Wataru Izumita, Norifumi Sugawara, Yukiteru Fujishima, Maki Asahi, Ryousei Sasaki, Takahiro Mine, Yasuhiko Tsukushi, Yuka Fujisawa, Ichiro Hanamura, Shugo Kowata, Yusei Aoki, Yoshiaki Okano, Shigeki Ito, Yuzo Suzuki, Tatsuo Oyake
Publikováno v:
Blood. 128:1607-1607
Background: Invasive fungal infections (IFIs) incur significant morbidity and mortality in neutropenic patients with hematological malignancies (HEM) after chemotherapy. The risk for these infections is related to the intensity and duration of neutro
Autor:
Yoji, Ishida, Yukiteru, Fujishima
Publikováno v:
Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine. 102(7)
Autor:
Yusei Aoki, Yoshiaki Okano, Shugo Kowata, Takayuki Masuda, Maki Asahi, Shigeki Ito, Yuzo Suzuki, Tatsuo Oyake, Yukiteru Fujishima, Norifumi Sugawara, Yoji Ishida
Publikováno v:
Blood. 126:4621-4621
BACKGROUND: Febrile neutropenia (FN) is often observed in hematological malignancy (HEM). Although most are considered to be due to bacterial infections, it is often difficult to specify the focuses and pathogens of infections in FN patients. Preseps
Autor:
Maki Asahi, Norifumi Sugawara, Yukiteru Fujishima, Yusei Aoki, Shigeki Ito, Yuzo Suzuki, Tatsuo Oyake, Yoshiaki Okano, Shugo Kowata, Yoji Ishida
Publikováno v:
Annals of Oncology. 26:vii109
Autor:
Yusei Aoki, Yukiteru Fujishima, Shigeki Ito, Shugo Kowata, Maki Asahi, Tatsuo Oyake, Yoji Ishida, Ichiro Hanamura, Takahiro Mine, Yuka Fujisawa, Yasunori Nakagawa, Norifumi Sugawara
Publikováno v:
Blood. 124:4954-4954
BACKGROUND: Febrile neutropenia (FN) is often observed in cases of hematological malignancy such as acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL) and myelodysplastic syndrome (MDS). Carbapenem antibiotics having a potent and broad
Autor:
Yoshiaki Okano, Yukiteru Fujishima, Yoji Ishida, Kazunori Murai, Tadashi Shimoyama, Shigeki Ito, Tatsuo Oyake, Shugo Kowata
Publikováno v:
Blood. 124:1456-1456
Background: Immune thrombocytopenia (ITP) is an autoimmune disease in which anti-platelet antibody (APA) is produced. APA-coated platelets are captured and phagocytized by macrophages in the spleen. Recent study revealed that spleen tyrosine kinase (